Award-winning King's College London researcher to join ISAB for in vitro dissolution collaboration
Dr Abhinav Kumar, a Research Associate in the Institute of Pharmaceutical Science is joining Inhalation Sciences AB (ISAB) at their lab in Stockholm to collaborate on in vitro dissolution research.
'Our team at KCL has developed simulated human lung lining fluid. With ISAB’s expertise in in vitro dissolution testing we hope to generate exemplary data. Working with ISAB lets me engage with a group of world class scientists, who continually challenge me intellectually and further my professional development' says Dr Kumar, in an interview with Inhalation Sciences. Read the full interview.
This collaboration was made possible by a Sparking Impact grant from the Biotechnology and Biological Sciences Research Council (BBSRC).
King’s received a £100,000 Sparking Impact grant from the BBSRC in 2013 to enable researchers in the biosciences to achieve greater impact from their research. A team at King’s devised a competition open to all researchers - staff and PhD students - to fund short-term projects that would generate impact from the existing BBSRC grant portfolio.
The funding was flexible and could be used for proof-of-concea t; to validate new technologies and tools; and to foster open innovation. Projects could be based on any BBSRC grant made to King’s and support from industry (although not necessarily financial) was mandatory. The majority of the projects involved SMEs, had short timeframes (24 weeks) and all applicants were required to produce a detailed project plan after attending a workshop. All applications were reviewed by internal and external assessors.
The competition proved highly popular – especially with young researchers and PhD students. For some, this was their first real ‘grant’ and experience of working with a company partner. In the first year of the competition eleven successful projects were funded.
Dr Abhinav Kumar and Dr Ben Forbes won a Sparking Impact Award of £10,000 to enable them to work with two companies to develop their simulated human lung-lining fluid. The work with ISAB (Inhalation Sciences AB) is a direct follow-on from the studies funded by their Award and a great example of ‘Sparking Impact’ from an initial BBSRC award.